Загрузка...
A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy
PURPOSE: Some breast cancer survivors report cognitive difficulties greater than 1 year after chemotherapy. Acetylcholinesterase inhibitors (AChEI) may improve cognitive impairment. We conducted a randomized, placebo-controlled, pilot study to assess the feasibility of using the AChEI, donepezil, to...
Сохранить в:
| Опубликовано в: : | J Cancer Surviv |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4930878/ https://ncbi.nlm.nih.gov/pubmed/26130292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11764-015-0463-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|